Marksans Pharma Limited has announced the launch of a 100-day campaign titled "Saksham Niveshak" aimed at helping shareholders update their KYC, bank details, and nominations while ensuring the timely claim of unclaimed dividends. This initiative aligns with the Investor Education and Protection Fund (IEPF) Authority’s guidelines issued by the Ministry of Corporate Affairs (MCA) on 16th July 2025.

The campaign provides an opportunity for shareholders who have not claimed dividends for any financial year since 2017-18 or have pending updates regarding KYC, bank account details, nomination, and specimen signature. The goal is to prevent unclaimed dividends from being transferred to the Investor Education and Protection Fund (IEPF) and to promote transparency in dividend distribution.

Shareholders holding physical shares are requested to submit relevant forms, including Form ISR-1, ISR-2, ISR-3, SH-13, and SH-14, along with supporting documents for registration or updating their KYC details. These forms can be downloaded from the company’s website at Marksans Pharma Forms or the RTA website at Bigshare Services.

For shareholders holding shares in electronic form, it is essential to update or modify the details with their respective depository participants to ensure smooth processing of dividends. The company emphasizes that all claims and updates must be completed before 31st October 2025 to avoid automatic transfer of unclaimed dividends to the IEPF.

According to company records, dividends declared from FY2018 to FY2024 remain unclaimed for certain shareholders. Details of unclaimed dividends can be accessed on the company website, allowing shareholders to verify and take appropriate action.

The Saksham Niveshak campaign also aims to empower shareholders by ensuring direct claim processing without the intervention of third parties, thereby fostering transparency, efficiency, and investor engagement. Marksans Pharma encourages shareholders to reach out to the company or RTA for assistance regarding unclaimed dividends or KYC updates.

Shareholders can contact Bigshare Services Private Limited at Office No. S6-2, 6th Floor, Pinnacle Business Park, Near Ahura Centre, Mahakali Caves Road, Andheri (East), Mumbai 400093; email: investors@bigshareonline.com, or call 022 62638200. Queries can also be directed to the Company Secretary at 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai – 400053; email: companysecretary@marksanspharma.com, or call 022 40012000.

This campaign underscores Marksans Pharma’s commitment to shareholder engagement, transparency, and compliance with regulatory requirements, ensuring that investors receive their entitled dividends and can update critical account information efficiently. Shareholders are strongly encouraged to act promptly to avoid any future inconvenience related to unclaimed dividends.

The Upcoming IPOs in this week and coming weeks are Karbonsteel Engineering, Taurian MPS, L. T. Elevator, Galaxy Medicare, Airfloa Rail Technology, Dev Accelerator, Jay Ambe Supermarkets, Urban Company, Shringar House of Mangalsutra, .

The Current active IPO are Nilachal Carbo Metalicks, Krupalu Metals, Vashishtha Luxury Fashion, Sharvaya Metals, Vigor Plast India, Austere Systems.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.